This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Small cell lung cancer, helper endpoint
HLP_C3_SCLC
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1236 |
4. Check minimum number of eventsNone |
1236 |
5. Include endpointsNone |
1236 |
6. Filter based on genotype QC (FinnGen only) |
1098 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Small cell lung cancer, helper endpoint
based on the number of shared cases.
Similar with more cases:
- Small cell lung cancer
- Small cell lung cancer, including Hilmo
- Malignant neoplasm of bronchus and lung
- Malignant neoplasm of bronchus and lung, including Hilmo
- Malignant neoplasm of respiratory system and intrathoracic organs
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1098 | 270 | 828 |
| Unadjusted period prevalence (%) | 0.31 | 0.10 | 0.38 |
| Median age at first event (years) | 70.99 | 69.12 | 71.61 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1134
- Matched controls
- 11340
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UGC12
NOMESCO Finland
Flexible bronchoscopy
10.4
312.9
456
691
L01CB01
ATC
etoposide; systemic
289.1
307.7
314
15
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
+∞
307.7
697
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
23.7
307.7
310
177
130
Kela drug reimbursment
Malignant tumour
17.8
307.7
647
787
H02AB02
ATC
dexamethasone; systemic
11.3
307.7
489
711
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
39.6
307.7
229
72
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
951.7
307.7
337
5
C34.86
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
850.6
278.8
263
*
A03FA01
ATC
metoclopramide; systemic, rectal
7.2
246.3
604
1552
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
12.2
245.8
278
295
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
7.6
237.1
459
928
8041/3-C34.1
ICD-O-3
Small cell carcinoma, NOS, of upper lobe, lung
+∞
217.9
202
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
18.8
214.4
178
111
WF049
NOMESCO Finland
Radiotherapy of metastasis
12.5
206.8
222
216
C34.36
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma
1173.9
205.9
195
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
11.3
203.3
236
257
A04AA01
ATC
ondansetron; systemic, rectal
8.8
198.3
293
434
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
18.5
175.3
145
89
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
17.0
173.0
150
101
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
26.3
164.5
116
49
WF004
NOMESCO Finland
Palliative radiotherapy
13.9
161.8
158
131
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
41.4
144.6
88
23
8041/3-C34.3
ICD-O-3
Small cell carcinoma, NOS, of lower lobe, lung
+∞
135.2
127
*
C34.96
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary microcellular carcinoma
686.6
127.0
123
*
Z51.5
ICD-10 Finland
Palliative care
5.2
121.9
314
781
C34.06
ICD-10 Finland
Malignant tumor of the main bronchial microcellular carcinoma
377.4
105.0
104
*
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
33.8
104.3
67
21
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
11.5
102.1
110
105
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
24.4
96.1
69
30
TGD00
NOMESCO Finland
Needle biopsy of lung
32.2
93.6
61
20
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
11.8
85.0
89
81
C34.2
ICD-10 Finland
Malignant neoplasm: Middle lobe, bronchus or lung
39.3
79.6
49
13
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
18.5
77.9
63
36
R84
ICPC
Malignant neoplasm bronchus/lung
25.7
76.9
54
22
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
6.8
75.6
126
205
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
9.5
75.3
92
104
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
10.0
72.4
85
91
L03AA13
ATC
pegfilgrastim; parenteral
6.6
70.2
120
200
N02AA05
ATC
oxycodone; systemic
3.1
69.1
415
1772
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
13.8
62.6
59
45
A04AA55
ATC
palonosetron, combinations; systemic
7.8
61.3
88
121
8041/3-C34.0
ICD-O-3
Small cell carcinoma, NOS, of main bronchus
+∞
61.0
58
*
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
10.7
59.5
66
65
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
21.2
56.8
43
21
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
11.1
53.6
58
55
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
8.2
52.8
72
93
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.9
52.3
333
1436
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
6.2
51.2
91
157
C34.26
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung microcellular carcinoma
+∞
50.4
48
*
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
15.9
49.6
43
28
A98
ICPC
Health maint/preventive medicine
0.4
49.1
529
7768
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
11.3
48.0
51
47
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
6.0
47.8
88
157
XX3DW
NOMESCO Finland
Time consuming IT work
3.3
46.3
200
687
8041/3-C34.2
ICD-O-3
Small cell carcinoma, NOS, of middle lobe, lung
+∞
46.2
44
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
4.0
44.6
139
384
D70.82
ICD-10 Finland
Drug-induced neutropenia
9.1
44.3
55
63
A04AA02
ATC
granisetron; systemic, transdermal
4.1
43.8
132
356
WF002
NOMESCO Finland
Radical radiotherapy
3.9
41.1
133
377
N07BA03
ATC
varenicline; oral
5.8
37.3
70
127
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.6
37.0
72
135
1623B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA MICROCELLURE]
185.7
34.9
36
*
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
10.9
33.2
36
34
JN4AD
NOMESCO Finland
Body CT examination
2.7
33.1
203
840
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
6.4
32.0
54
88
L01XX17
ATC
[U] topotecan
+∞
31.4
30
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.3
29.6
122
403
N40
ICD-10 Finland
Hyperplasia of prostate
0.4
29.3
145
3245
WW200, ,
SPAT
0.2
28.7
47
1928
GD1AD
NOMESCO Finland
Thorax CT examination
3.3
28.4
116
381
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
6.3
28.2
48
79
N02AA01
ATC
morphine; systemic, rectal
4.5
26.6
67
157
ZX070
NOMESCO Finland
Intensity modified radiotherapy
5.5
26.6
52
98
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
5.2
25.6
54
109
L01CE01
ATC
topotecan; systemic
+∞
25.1
24
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.2
25.0
105
350
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
5.7
24.8
47
86
1625B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA MICROCELLURE]
234.5
22.7
23
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
9.2
22.1
27
30
R03AK03
ATC
[U] fenoterol and ipratropium bromide
2.4
21.8
164
740
ZX080
NOMESCO Finland
Image guided radiotherapy
5.2
21.8
45
89
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
7.1
21.7
33
48
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.3
21.6
83
262
G04CA02
ATC
tamsulosin; oral
0.5
21.6
188
3443
L03AA14
ATC
lipegfilgrastim; parenteral
6.1
21.3
37
62
I10
ICD-10 Finland
Essential (primary) hypertension
0.5
21.3
448
6186
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.2
20.8
40
1518
R03BB04
ATC
tiotropium bromide; inhalant
2.2
20.7
212
1089
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
5.9
20.7
37
64
N02BE01
ATC
paracetamol; systemic, rectal
0.6
20.6
638
7939
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
19.8
19.6
29
15
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.8
19.0
60
166
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
4.2
18.4
50
124
SAA02
NOMESCO Finland
Basic examination of mouth
0.5
18.4
247
3969
Z72.0
ICD-10 Finland
Tobacco use
4.8
18.1
41
88
N06DA02
ATC
donepezil; oral
0.1
18.0
7
638
TQW40, ,
SPAT
0.1
18.0
*
534
JN4BD
NOMESCO Finland
Extensive body CT
2.2
17.7
161
785
SFA20
NOMESCO Finland
Two-surface restoration
0.5
17.3
203
3424
A06AH03
ATC
naloxegol; oral
5.1
17.0
36
73
EB4VA, ,
NOMESCO Finland
0.1
16.8
6
584
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
5.5
16.4
32
60
H02AB06
ATC
prednisolone; systemic
1.7
16.4
551
4071
SAA01
NOMESCO Finland
Simple examination of mouth
0.6
16.0
314
4580
N06DX01
ATC
memantine; oral
0.1
16.0
11
864
H25.1
ICD-10 Finland
Senile nuclear cataract
0.5
15.8
186
3158
S18
ICPC
Laceration/cut
0.5
15.8
232
3678
SFA10
NOMESCO Finland
One-surface restoration
0.5
15.7
201
3324
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.5
15.4
238
3726
P20
ICPC
Memory disturbance
0.3
15.4
48
1408
M79.6
ICD-10 Finland
Pain in limb
0.5
15.3
162
2851
C34.89
ICD-10 Finland
Malignant overall tumor of the bronchus and lung other or unspecified histology
13.3
15.2
26
20
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
29.0
15.2
20
7
J01DB01
ATC
cefalexin; oral
0.6
15.1
552
6921
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
14.2
15.1
25
18
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
16.7
14.8
23
14
1628B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,CA MICROCELLURE]
+∞
14.6
14
*
WW500
NOMESCO Finland
Blood transfusion
2.9
14.6
69
246
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.3
14.6
45
1330
SFA30
NOMESCO Finland
Three-surface restoration
0.5
14.4
141
2557
M01AH05
ATC
etoricoxib; oral
0.6
14.3
270
4021
L03AA02
ATC
filgrastim; parenteral
3.5
14.1
48
140
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.4
14.0
94
1961
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.5
13.9
139
2510
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
17.8
13.9
21
12
C10AA05
ATC
atorvastatin; oral
0.6
13.8
256
3839
Z02.4
ICD-10 Finland
Examination for driving licence
0.5
13.5
152
2645
M25.5
ICD-10 Finland
Pain in joint
0.4
13.5
80
1753
A04AD12
ATC
aprepitant; systemic
4.7
13.3
31
68
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
11.6
13.3
24
21
N03AX14
ATC
levetiracetam; systemic
3.7
13.2
42
117
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
13.2
441
3201
R04.2
ICD-10 Finland
Haemoptysis
2.7
13.1
70
267
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.4
13.1
87
1824
OAB44, ,
SPAT
0.1
13.0
5
458
XKD00
NOMESCO Finland
Uroflowmetry
0.4
13.0
86
1807
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.5
12.7
43
125
C34.20
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung without histology
32.4
12.6
16
5
Z01.2
ICD-10 Finland
Dental examination
0.5
12.4
146
2516
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
11.8
12.3
22
19
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.5
12.3
80
336
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.2
12.2
13
742
I87.1
ICD-10 Finland
Compression of vein
38.0
12.2
15
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
16.1
12.2
19
12
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.4
12.1
51
1304
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
12.1
339
2345
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.1
11.9
116
579
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
11.8
72
1570
G04CB01
ATC
finasteride; oral
0.4
11.7
82
1692
L57.0
ICD-10 Finland
Actinic keratosis
0.3
11.7
26
923
C34.09
ICD-10 Finland
Malignant tumor of the main bronchus other or unspecified histology
12.7
11.6
20
16
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.6
11.6
175
2810
L17
ICPC
Foot/toe symptom/complaint
0.5
11.6
109
2026
D19
ICPC
Teeth/gum symptom/complaint
0.4
11.6
70
1532
G04CB02
ATC
dutasteride; oral
0.3
11.4
25
897
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.3
11.4
42
1143
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
0.6
11.3
224
3349
SDA02
NOMESCO Finland
Periodontal treatment, brief
0.5
11.3
101
1912
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
9.0
11.3
23
26
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
3.0
11.2
51
178
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.4
11.2
65
1449
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.4
11.2
82
364
Z71.8
ICD-10 Finland
Other specified counselling
0.5
11.1
104
1940
SDA03
NOMESCO Finland
Periodontal treatment
0.5
11.0
119
2119
GEA00
NOMESCO Finland
Mediastinoscopy
14.0
11.0
18
13
R4110, ,
SPAT
0.2
11.0
20
801
EB1VA, ,
NOMESCO Finland
0.2
11.0
20
800
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
0.4
10.9
64
1422
K02.1
ICD-10 Finland
Caries of dentine
0.6
10.9
237
3469
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
0.6
10.8
213
3198
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.6
10.8
204
3094
C10AA07
ATC
rosuvastatin; oral
0.5
10.7
133
2267
L08
ICPC
Shoulder symptom/complaint
0.4
10.5
61
1361
1622B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Main bronchus[NEOPL MAL BRONCH PRINCIP,CA MICROCELLURE]
+∞
10.4
10
*
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
0.3
10.4
26
867
SPAT1325
SPAT
Vaccination
0.6
10.4
169
2673
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
10.4
64
1394
UKC02
NOMESCO Finland
Cystoscopy
0.5
10.4
94
1777
G04BD12
ATC
mirabegron; oral
0.3
10.4
27
880
K03.64
ICD-10 Finland
Dental calculus supragingival
0.4
10.1
67
1420
L82
ICD-10 Finland
Seborrhoeic keratosis
0.4
10.1
50
1193
WX110
NOMESCO Finland
Infiltration anesthesia
0.7
10.1
383
4970
H02
ICPC
Hearing complaint
0.4
10.0
49
1177
TGA30
NOMESCO Finland
Thoracocentesis
4.9
10.0
22
46
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.4
9.9
55
1253
G04CA01
ATC
alfuzosin; oral
0.4
9.8
68
1419
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
7.5
9.7
22
30
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
7.9
9.6
21
27
SDA01
NOMESCO Finland
Periodontal treatment, very brief
0.4
9.5
65
1364
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.5
9.5
83
1592
Z51.0
ICD-10 Finland
Radiotherapy session
3.9
9.4
27
70
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
100.9
9.4
10
*
L15
ICPC
Knee symptom/complaint
0.5
9.4
73
1462
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.3
9.4
24
792
1624B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Middle lobe, bronchus or lung[NEOPL MAL LOBI MEDII PULMONIS,CA MICROCELLURE]
+∞
9.4
9
*
WZC00, ,
SPAT
0.3
9.3
22
755
SPAT1312
SPAT
General health counselling
0.5
9.2
110
1909
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.9
9.2
26
67
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
7.8
9.1
20
26
J01MA14
ATC
moxifloxacin; systemic
1.9
9.0
114
624
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.1
9.0
5
352
A97
ICPC
No disease
0.4
9.0
61
1283
B01AF02
ATC
apixaban; oral
0.4
8.9
51
1149
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2.5
8.9
57
239
L12
ICPC
Hand/finger symptom/complaint
0.4
8.8
34
911
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
3.6
8.7
28
79
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.6
8.6
49
194
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
0.6
8.5
227
3213
C34.35
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma
20.2
8.5
12
6
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.4
8.5
44
1031
KMAK, ,
NOMESCO Finland
0.6
8.4
201
2918
H91.1
ICD-10 Finland
Presbycusis
0.3
8.4
18
656
Z01.7
ICD-10 Finland
Laboratory examination
0.4
8.4
35
904
1240
FHL
Bronchoscopy
3.0
8.2
35
118
H13
ICPC
Plugged feeling ear
0.5
8.2
83
1525
OAB42, ,
SPAT
0.3
8.2
18
648
SPAT1053
SPAT
Memory test
0.5
8.2
70
1359
D82
ICPC
Teeth/gum disease
0.6
8.2
111
1864
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
4.8
8.1
18
38
M01AX05
ATC
glucosamine; oral
0.5
8.1
85
1541
C34.29
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other or unspecified histology
22.2
8.0
11
5
D01BA02
ATC
terbinafine; oral
0.6
7.9
112
1859
116
Kela drug reimbursment
Prostate cancer
0.4
7.9
30
809
UJF32
NOMESCO Finland
Coloscopy
0.6
7.9
131
2083
L13
ICPC
Hip symptom/complaint
0.5
7.8
63
1249
A06AC01
ATC
ispaghula (psylla seeds); oral
0.6
7.8
126
2018
L28
ICPC
Limited function/disability (L)
0.5
7.8
94
1634
WX290
NOMESCO Finland
Other blockage of nerve
0.6
7.7
157
2373
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.0
7.6
87
461
WX320
NOMESCO Finland
Spinalanesthesy
0.6
7.5
113
1849
C08CA01
ATC
amlodipine; oral
0.7
7.4
264
3540
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
3.5
7.4
25
73
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.6
7.4
132
2065
C09CA01
ATC
losartan; oral
0.6
7.4
134
2088
N17
ICPC
Vertigo/dizziness
0.4
7.4
33
827
R85
ICPC
Malignant neopl respiratory other
13.5
7.4
12
9
SCA01
NOMESCO Finland
Preventive oral health care, short
0.5
7.3
71
1322
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.6
7.3
133
2067
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.1
7.3
69
342
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.6
7.2
40
156
S29
ICPC
Skin symptom/complaint other
0.5
7.2
66
1255
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
5.8
7.2
19
33
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.6
7.2
123
1947
R33
ICD-10 Finland
Retention of urine
0.5
7.2
50
1047
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
0.2
7.2
12
507
2391A
ICD-9 Finland
Neoplasm of unspecified nature, Respiratory system
4.5
7.2
17
38
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.4
7.1
38
882
E0000UV, ,
ATC
0.7
7.0
205
2869
K85
ICPC
Elevated blood pressure
0.5
7.0
65
1227
D06BB10
ATC
imiquimod; topical
0.2
6.9
5
294
C34
ICD-10 Finland
Malignant neoplasm of bronchus and lung
13.9
6.9
11
8
C34.15
ICD-10 Finland
Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma
8.3
6.8
14
17
P70
ICPC
Dementia
0.1
6.8
*
228
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
0.3
6.8
21
626
J01FA06
ATC
roxithromycin; oral
1.4
6.8
388
3048
R31
ICD-10 Finland
Unspecified haematuria
0.5
6.8
58
1128
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
0.6
6.8
114
1814
SPAT1043
SPAT
Audiometry
0.4
6.8
29
739
G30.8
ICD-10 Finland
Other Alzheimer disease
0.1
6.8
*
248
R42
ICD-10 Finland
Dizziness and giddiness
0.6
6.7
116
1834
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
0.3
6.7
20
606
M01AE01
ATC
ibuprofen; systemic, rectal
0.7
6.7
636
7249
Z01.1
ICD-10 Finland
Examination of ears and hearing
0.5
6.6
53
1055
R03DA04
ATC
theophylline; systemic, rectal
1.7
6.6
112
672
M54.5
ICD-10 Finland
Low back pain
0.6
6.6
145
2162
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.6
6.6
96
1587
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
0.4
6.6
35
812
H81
ICPC
Excessive ear wax
0.5
6.5
83
1426
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
0.3
6.5
23
640
U02
ICPC
Urinary frequency/urgency
0.4
6.5
35
808
C10AX09
ATC
ezetimibe; oral
0.5
6.5
59
1123
A69.2
ICD-10 Finland
Lyme disease
0.2
6.5
6
305
C38.3
ICD-10 Finland
Malignant neoplasm: Mediastinum, part unspecified
70.2
6.4
7
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
14.4
6.4
10
7
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
14.4
6.4
10
7
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.6
6.4
100
1623
Z96.1
ICD-10 Finland
Presence of intraocular lens
0.5
6.4
81
1392
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
0.5
6.3
78
1353
D01AE16
ATC
amorolfine; topical
0.4
6.3
34
787
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.3
6.3
14
499
Z00.0
ICD-10 Finland
General medical examination
0.5
6.3
80
1376
R01AD12
ATC
fluticasone furoate; nasal
0.5
6.3
78
1349
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
0.3
6.3
19
571
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
0.4
6.3
36
810
1629B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,CA MICROCELLURE]
+∞
6.3
6
*
8041/3-C34.8
ICD-O-3
Small cell carcinoma, NOS, of overlapping lesion of lung
+∞
6.3
6
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.1
6.3
60
299
H91.9
ICD-10 Finland
Hearing loss, unspecified
0.2
6.2
9
352
F17.22
ICD-10 Finland
Addiction-related addiction currently uses controlled substitution treatment
26.8
6.2
8
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.2
6.2
53
252
K05.31
ICD-10 Finland
Periodontitis pronounced
1.7
6.2
106
639
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
3.4
6.2
21
62
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
3.0
6.1
26
88
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
0.3
6.1
18
550
VALMI, ,
NOMESCO Finland
0.5
6.1
63
1153
F01.9
ICD-10 Finland
Vascular dementia, unspecified
0.1
6.1
*
181
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
0.1
6.1
*
181
Y77
ICPC
Malignant neoplasm prostate
0.2
6.1
7
310
N30.0
ICD-10 Finland
Acute cystitis
0.5
6.1
45
919
B01AF01
ATC
rivaroxaban; oral
0.5
6.0
48
958
M01AC06
ATC
meloxicam; systemic, rectal
0.7
6.0
176
2475
A04AA03
ATC
tropisetron; systemic
10.1
6.0
11
11
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
3.3
6.0
22
68
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.3
6.0
22
68
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
218
136
19.61
263.99
1.2
1.1
—
—
—
0
0
161
263
6.97
96.83
1.2
1.5
—
—
—
0
0
158
405
4.37
56.55
1.9
2.8
—
—
—
0
0
103
204
5.45
50.10
1.3
1.3
—
—
—
0
0
453
7052
0.40
47.26
6.3
7.3
41.81
40.60
mmol/mol
1.74
395
6441
264
1077
2.89
45.27
2.1
4.2
32.34
26.25
ug/l
0.20
242
920
78
2913
0.21
44.47
1.7
2.0
1.60
1.29
mmol/l
1.10
65
2356
487
7229
0.43
42.10
4.5
6.3
2.53
2.48
mmol/l
0.50
425
6528
469
7059
0.43
41.87
4.1
5.4
4.36
4.34
mmol/l
0.14
412
6411
462
6989
0.43
41.66
4.2
5.3
1.32
1.41
mmol/l
4.53
402
6287
323
1549
2.52
39.54
4.3
3.2
0.77
0.82
mmol/l
9.97
313
1445
447
6786
0.44
39.37
4.3
5.0
1.84
2.08
mu/l
2.81
391
6038
494
7194
0.44
38.44
4.7
5.7
6.37
6.13
mmol/l
2.61
427
6397
580
7915
0.45
36.87
40.6
30.8
124.92
131.91
g/l
24.11
572
7767
580
7913
0.45
36.79
40.3
30.5
4.13
4.36
e12/l
21.30
561
7665
580
7913
0.45
36.79
40.7
31.2
37.63
39.37
%
15.28
571
7756
580
7913
0.45
36.79
40.4
30.6
255.29
235.41
e9/l
7.32
564
7695
580
7912
0.45
36.75
40.2
30.5
92.58
92.00
fl
2.14
572
7765
581
7916
0.45
36.57
40.3
30.6
7.94
7.05
e9/l
12.46
562
7666
581
7877
0.46
35.09
36.5
27.3
77.45
88.79
umol/l
10.30
570
7731
456
6728
0.46
34.53
3.8
4.5
1.44
1.26
mmol/l
4.82
396
6007
498
7067
0.47
32.78
28.8
20.3
80.40
71.83
ml/min/173m2
16.13
465
6625
223
4280
0.40
32.73
4.1
6.0
1.88
4.59
ug/l
2.10
193
3775
581
7808
0.48
32.56
32.6
25.1
4.02
4.03
mmol/l
0.28
569
7604
581
7803
0.48
32.38
32.8
24.9
137.10
139.65
mmol/l
32.83
570
7608
573
7694
0.48
31.04
17.8
13.1
28.05
25.31
u/l
1.74
561
7381
220
4133
0.42
29.63
1.9
2.3
88.10
92.72
pmol/l
0.74
124
2256
159
3414
0.38
29.32
3.6
5.0
21.69
21.93
%
0.06
71
1816
351
5507
0.47
28.87
3.6
3.9
15.48
15.07
pmol/l
1.68
302
4866
181
3501
0.43
24.89
1.8
2.3
71.11
79.01
nmol/l
3.53
157
3040
132
2862
0.39
23.64
1.6
1.8
17.36
19.57
nmol/l
0.98
120
2409
400
5774
0.53
22.88
36.0
27.2
331.25
331.18
g/l
0.05
393
5724
198
3571
0.46
21.85
2.7
3.0
281.54
160.30
ug/l
4.43
182
3247
106
2461
0.37
21.83
2.6
3.5
0.79
0.84
ug/l
0.16
73
1762
581
7453
0.55
21.45
29.7
20.7
32.38
29.39
mg/l
1.50
561
6396
420
5890
0.54
20.84
35.4
25.3
14.74
13.98
%
19.67
415
5799
271
4193
0.54
17.58
3.7
4.2
0.00
0.00
estimate
0.50
81
929
277
4252
0.54
17.45
3.7
4.2
0.00
3.36
estimate
0.80
83
958
283
4284
0.55
16.77
3.7
4.2
0.00
0.34
estimate
0.51
81
893
175
3036
0.50
15.96
3.1
3.4
6.96
7.40
mmol/l
0.83
137
2504
185
3099
0.52
14.89
4.0
4.1
21.57
9.96
mg/mmol
0.88
117
1976
35
83
4.32
13.69
1.2
1.4
—
—
—
0
0
25
46
5.53
13.10
1.1
1.2
100.94
101.32
ug/l
0.00
20
21
154
2642
0.52
13.01
2.5
2.3
3.27
2.96
mg/l
1.03
137
2258
36
95
3.88
12.24
1.2
1.5
258.30
276.87
mosm/kgh2o
3.48
27
71
461
5834
0.65
11.29
4.2
4.4
23.61
14.81
mm/h
14.41
432
5358
51
181
2.90
10.92
1.3
1.4
3545.11
1685.56
e6/l
1.03
45
121
209
3154
0.59
10.84
4.0
4.3
0.00
0.03
estimate
2.59
72
771
37
109
3.48
10.76
1.4
1.4
12.41
13.99
u/l
0.85
37
99
45
157
2.94
9.95
1.3
1.4
24801.06
50449.42
e6/l
0.73
36
91
249
3502
0.63
9.29
2.5
2.4
—
—
—
0
0
41
149
2.82
8.46
1.2
1.3
416.80
311.94
u/l
0.50
41
141
36
125
2.94
8.07
1.2
1.2
11.06
11.95
u/l
0.16
36
115
114
1888
0.56
7.99
4.2
4.4
1.02
1.02
kg/l
0.48
90
1306
456
5573
0.70
7.94
4.2
5.2
35.33
998.08
e6/l
—
9
105
123
1920
0.60
6.79
1.7
1.8
1084.76
1159.38
nmol/l
0.42
97
1422
131
2013
0.61
6.78
1.7
1.8
434.10
16924456.58
pmol/l
1.18
109
1619
106
632
1.75
6.40
1.3
1.5
—
—
—
0
0
100
599
1.73
5.95
3.9
3.7
2.80
1.99
mmol/l
0.87
82
444
379
4636
0.73
5.92
5.1
3.4
103.83
57.67
u/l
4.09
351
4267
167
2353
0.66
5.75
2.8
3.0
340.79
368.36
umol/l
1.77
145
1986
154
2203
0.65
5.70
3.7
3.8
0.00
0.06
estimate
1.09
64
710
112
702
1.66
5.65
4.5
3.8
5.37
5.15
kpa
1.53
106
664
176
2433
0.67
5.47
3.7
4.2
0.00
0.01
estimate
0.78
65
814
258
3324
0.71
5.42
2.8
3.4
1640.27
2130.43
ng/l
0.56
237
2919
31
691
0.43
5.28
1.7
2.3
11.41
12.03
nmol/l
0.22
24
595
92
1446
0.60
5.13
1.1
1.2
0.82
1.78
u/ml
1.86
18
363
116
1720
0.64
5.03
2.1
2.7
11.29
12.02
umol/l
0.49
109
1603
65
1110
0.56
4.98
1.3
1.3
23.86
16.19
u/ml
0.31
21
379
72
1194
0.58
4.95
1.3
1.3
121.17
37.99
iu/ml
1.21
25
378
536
4606
1.31
4.78
9.6
6.9
10.84
12.78
umol/l
2.39
526
4390
18
58
3.14
4.65
2.2
2.9
1.25
1.02
%
0.23
18
58
316
3867
0.75
4.59
2.6
3.1
—
—
estimate
—
0
0
529
4566
1.30
4.46
14.0
9.4
4.79
4.33
e9/l
3.39
482
3932
108
1584
0.65
4.43
2.1
2.7
2.18
2.21
g/l
0.20
97
1471
23
533
0.42
4.35
1.3
1.4
—
—
—
0
0
108
721
1.55
4.23
2.5
2.1
514.17
386.94
nmol/l
2.79
103
662
562
6302
0.79
3.93
13.8
8.7
105.03
83.76
u/l
7.37
554
5909
234
1831
1.35
3.90
1.9
2.0
—
—
—
0
0
224
2826
0.74
3.88
2.3
2.3
273.85
241.84
u/l
0.16
208
2653
105
1488
0.68
3.61
2.3
2.7
20.94
22.04
%
0.35
98
1389
26
124
2.12
3.16
3.2
3.6
—
—
—
0
0
15
352
0.42
3.00
2.0
2.1
3.94
3.46
ratio
0.65
15
298
12
38
3.18
2.85
1.2
1.5
3.20
3.34
mmol/l
0.04
12
32
80
548
1.49
2.85
1.4
1.5
—
—
—
0
0
71
1034
0.67
2.82
9.7
8.7
—
—
—
0
0
179
2217
0.77
2.61
2.7
2.8
7.21
3.88
e6/l
2.64
169
2031
75
1053
0.69
2.48
3.9
5.2
31.17
32.68
%
0.51
54
672
264
3105
0.80
2.47
3.0
3.7
55.29
116.65
e6/l
1.17
208
2468
21
401
0.51
2.44
1.2
1.4
—
66.96
—
0
33
6
12
5.02
2.40
1.3
1.2
—
—
—
0
0
20
386
0.51
2.40
1.5
3.6
59.38
72.26
mg/l
0.28
15
331
20
385
0.51
2.38
1.6
3.7
50.01
51.61
mg/l
0.04
14
334
159
1267
1.30
2.33
2.9
4.2
355.99
255.88
u/l
3.72
153
1189
13
288
0.45
2.31
3.2
1.5
—
—
—
0
0
18
351
0.50
2.25
1.6
3.5
1.43
3.83
ratio
1.29
11
214
34
202
1.70
2.23
1.4
3.5
73.93
1584.59
u/ml
0.67
27
188
326
3713
0.83
2.17
4.0
4.5
26.84
105.02
ng/l
2.64
285
2977
23
122
1.90
2.17
1.6
1.5
—
—
—
0
0
9
207
0.43
2.08
1.7
1.6
—
—
—
0
0
180
2170
0.80
2.08
2.2
2.6
—
—
—
0
0
39
246
1.61
2.06
1.4
1.6
—
—
—
0
0
7
20
3.51
2.05
1.6
1.6
1689.71
91.75
nmol/24h
—
7
20
22
120
1.85
1.93
2.1
2.0
88.80
89.09
%
0.09
22
120
134
1655
0.78
1.91
2.5
3.3
0.88
0.92
e6/l
0.07
61
957
28
166
1.70
1.88
1.4
1.7
—
—
—
0
0
5
143
0.35
1.87
2.0
1.8
183.80
210.50
pmol/l
—
5
131
49
702
0.68
1.85
3.1
3.9
98.44
98.68
ng/l
0.00
42
600
16
80
2.01
1.80
1.3
1.7
—
—
—
0
0
41
274
1.51
1.73
1.3
1.7
—
—
—
0
0
5
13
3.86
1.71
1.0
1.1
—
—
—
0
0
30
188
1.61
1.67
1.5
1.4
—
—
—
0
0
35
228
1.55
1.66
2.0
2.7
33.03
32.85
umol/l
0.02
29
197
7
25
2.81
1.65
1.3
1.8
77.64
9.20
nmol/l
—
7
20
19
106
1.81
1.59
2.2
2.7
—
—
—
0
0
19
324
0.58
1.58
1.4
1.1
112.63
131.06
u/ml
—
6
119
71
927
0.75
1.56
2.4
2.6
4.00
6.58
ug/l
2.58
60
799
155
1295
1.23
1.56
2.0
2.0
—
—
—
0
0
36
240
1.52
1.56
1.4
1.4
—
—
—
0
0
36
240
1.52
1.56
1.4
1.4
—
—
—
0
0
52
712
0.72
1.56
1.2
1.3
—
—
—
0
0
15
272
0.55
1.56
3.3
3.5
1.40
1.67
mmol/l
1.01
15
262
12
233
0.51
1.55
3.4
3.7
7.46
7.72
mmol/l
0.13
12
225
219
1896
1.19
1.53
5.5
3.2
2.54
2.46
mmol/l
13.36
201
1687
0
44
0.00
1.51
0.0
1.7
—
39.18
—
0
44
15
79
1.91
1.49
1.3
1.5
—
—
—
0
0
163
1380
1.21
1.45
2.0
1.9
—
—
—
0
0
161
1887
0.83
1.42
3.6
4.4
166.73
329.22
ng/l
1.33
137
1663
235
2665
0.85
1.42
2.8
3.6
0.77
0.49
e6/l
0.90
181
2044
32
213
1.52
1.42
1.5
1.4
—
—
—
0
0
11
53
2.09
1.38
1.5
1.4
—
—
—
0
0
456
4206
1.14
1.38
7.2
6.6
1.21
1.20
mmol/l
0.46
445
3838
131
1562
0.82
1.38
2.5
3.5
2.95
1.34
e6/l
0.72
59
860
21
127
1.67
1.37
1.3
1.6
—
—
—
0
0
0
37
0.00
1.34
0.0
5.4
—
36.60
—
0
5
15
259
0.57
1.34
1.0
1.0
—
—
—
0
0
13
69
1.89
1.29
1.4
1.3
—
—
—
0
0
27
400
0.67
1.28
1.7
2.6
0.48
1.35
g/l
1.24
22
344
11
55
2.01
1.27
1.5
1.4
—
—
—
0
0
36
253
1.44
1.25
1.4
1.6
—
—
—
0
0
333
3032
1.14
1.21
5.6
3.6
2.37
2.34
mmol/l
3.62
311
2706
0
33
0.00
1.16
0.0
1.2
—
139.45
—
0
33
5
20
2.51
1.15
1.0
1.3
34.00
19.27
u/l
—
5
15
27
183
1.49
1.14
1.4
1.4
—
—
—
0
0
437
4062
1.12
1.13
6.0
5.3
32.03
34.34
g/l
12.52
413
3777
53
407
1.32
1.11
1.7
2.0
—
—
—
0
0
49
376
1.32
1.04
1.6
1.8
—
—
—
0
0
496
4662
1.11
1.03
7.5
7.3
1.21
1.21
mmol/l
0.63
426
3961
23
156
1.48
0.99
1.5
1.4
—
—
—
0
0
10
54
1.86
0.96
1.2
1.6
5.60
4.73
u/l
—
5
43
0
31
0.00
0.96
0.0
1.2
—
—
—
0
0
8
44
1.82
0.86
1.0
1.3
46.13
29.27
u/l
—
8
39
154
1731
0.87
0.85
1.5
1.7
2.17
1.62
mg/l
0.42
129
1376
6
31
1.94
0.84
4.0
2.0
0.59
0.61
mmol/l
—
6
31
6
31
1.94
0.84
1.2
1.8
—
—
—
0
0
6
31
1.94
0.84
1.2
1.8
—
—
—
0
0
31
231
1.35
0.83
2.7
2.4
352.04
82.27
ug/min
1.11
16
134
6
32
1.88
0.82
1.2
1.8
—
—
—
0
0
8
47
1.71
0.80
2.1
2.5
—
—
—
0
0
254
2759
0.90
0.80
2.7
2.6
64.33
90.74
u/l
0.43
227
2549
32
242
1.33
0.79
2.4
2.2
116.82
127.75
g/l
0.66
17
188
0
24
0.00
0.79
0.0
1.1
—
16.61
—
0
8
0
24
0.00
0.79
0.0
1.0
—
1637.63
—
0
24
0
25
0.00
0.79
0.0
1.8
—
15.51
—
0
17
12
187
0.64
0.78
1.0
1.4
—
—
—
0
0
13
82
1.59
0.78
1.2
1.5
—
—
—
0
0
13
82
1.59
0.78
1.2
1.5
—
—
—
0
0
13
82
1.59
0.78
1.2
1.5
—
—
—
0
0
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
54
658
0.81
0.77
2.2
1.7
1.86
1.66
%
0.49
42
531
6
34
1.77
0.76
1.0
1.3
26.93
35.89
u/l
—
6
26
29
380
0.76
0.75
1.0
1.2
755.67
228.49
u/ml
0.58
24
347
6
109
0.55
0.72
1.3
1.4
—
—
—
0
0
17
237
0.71
0.66
1.3
1.4
—
—
—
0
0
14
202
0.69
0.66
1.0
1.5
—
—
—
0
0
15
213
0.70
0.65
3.3
4.3
31.31
30.35
mg/l
—
10
163
7
44
1.59
0.65
1.1
1.7
—
—
—
0
0
7
44
1.59
0.65
1.1
1.7
—
—
—
0
0
7
44
1.59
0.65
1.1
1.7
—
—
—
0
0
7
44
1.59
0.65
1.1
1.7
—
—
—
0
0
12
178
0.67
0.65
1.3
1.3
—
—
—
0
0
5
29
1.73
0.64
1.2
1.1
—
—
—
0
0
13
87
1.50
0.63
1.3
1.3
—
—
—
0
0
6
104
0.57
0.62
1.2
1.6
—
—
—
0
0
58
683
0.84
0.61
4.1
3.1
61.78
59.55
ml/min/173m2
0.16
27
314
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
21
0.00
0.60
0.0
2.1
—
201.68
—
0
21
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
1.09
—
0
15
80
697
1.16
0.60
2.1
1.7
—
—
—
0
0
28
355
0.78
0.60
3.7
3.4
1.80
1.44
mmol/l
0.70
28
349
78
893
0.86
0.59
2.5
3.3
201.18
267.09
ng/l
0.80
71
824
0
22
0.00
0.59
0.0
1.4
—
9.41
—
0
22
0
23
0.00
0.58
0.0
1.3
—
147.62
—
0
23
502
5220
0.93
0.57
6.3
5.3
6.85
6.86
mmol/l
0.05
487
5011
5
86
0.58
0.56
1.2
1.4
—
—
—
0
0
91
1018
0.88
0.51
4.6
3.7
—
—
—
0
0
247
2625
0.92
0.50
5.2
3.3
45.52
36.97
u/l
0.52
232
2471
16
213
0.75
0.50
1.2
1.6
—
—
—
0
0
105
948
1.12
0.49
2.0
2.8
65.25
65.75
g/l
0.31
95
858
32
262
1.23
0.49
4.3
3.6
6.57
1.56
index
1.43
23
147
11
77
1.43
0.45
1.2
1.1
1.18
1.55
nmol/l
0.90
11
71
8
57
1.41
0.42
2.0
3.9
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
15
0.00
0.41
0.0
1.7
—
89.87
—
0
15
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
5
34
1.47
0.40
2.6
2.8
9.10
10.56
kpa
—
5
34
5
34
1.47
0.40
2.6
2.8
5.04
4.96
kpa
—
5
34
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
7
102
0.68
0.39
1.3
1.6
—
—
—
0
0
7
101
0.69
0.39
1.3
1.6
—
—
—
0
0
7
105
0.66
0.39
1.1
1.6
—
—
—
0
0
7
105
0.66
0.39
1.1
1.6
—
—
—
0
0
7
106
0.66
0.39
1.1
1.6
—
—
—
0
0
5
37
1.35
0.37
1.8
2.2
455.80
905.16
u/ml
—
5
37
5
37
1.35
0.37
1.8
1.9
58.00
45.84
umol/l
—
5
30
11
146
0.75
0.36
3.1
3.4
12.13
10.53
pmol/l
0.14
11
146
5
79
0.63
0.35
1.0
1.1
—
—
—
0
0
6
45
1.34
0.33
3.3
2.1
87.33
92.42
umol/l
—
6
45
11
144
0.76
0.33
1.3
1.3
—
—
—
0
0
134
1254
1.08
0.33
5.6
7.1
1.73
1.01
mmol/l
0.98
107
1019
6
46
1.31
0.33
1.2
1.2
—
—
—
0
0
95
1027
0.92
0.32
3.3
2.9
12.50
9.59
umol/l
0.58
80
919
22
262
0.84
0.31
1.8
3.4
0.77
0.85
nmol/l
0.44
15
219
7
54
1.30
0.30
1.3
2.2
—
—
—
0
0
20
239
0.83
0.30
1.4
1.5
302.67
257.44
ug/g
0.41
12
148
7
56
1.25
0.29
1.1
1.1
—
—
—
0
0
89
959
0.92
0.29
5.7
6.8
11.12
11.78
mmol/l
0.24
80
917
133
1258
1.06
0.26
5.6
7.1
10.22
11.64
kpa
3.43
122
1209
133
1258
1.06
0.26
5.6
7.1
5.10
5.09
kpa
0.04
122
1207
5
71
0.70
0.26
1.2
1.1
—
—
—
0
0
17
142
1.20
0.24
1.5
1.8
3.20
4.87
iu/l
—
7
60
16
191
0.84
0.24
1.1
1.2
16.80
3.25
u/ml
—
6
27
16
191
0.84
0.24
1.2
1.2
569.06
533.31
mg/l
0.15
16
178
6
81
0.74
0.24
1.5
1.3
68.22
29.57
iu/l
—
6
67
17
143
1.19
0.23
1.1
1.4
—
—
—
0
0
27
237
1.14
0.23
1.9
1.5
25.00
22.48
u/ml
—
5
41
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
2.6
—
0.70
—
0
10
0
10
0.00
0.21
0.0
1.5
—
19.30
—
0
10
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
8
101
0.79
0.21
1.3
1.6
—
—
—
0
0
12
145
0.83
0.21
1.3
2.5
—
1520.71
—
0
14
0
13
0.00
0.21
0.0
8.8
—
10.92
—
0
13
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
48
1.25
0.20
1.2
1.2
—
—
—
0
0
6
48
1.25
0.20
1.2
1.2
—
—
—
0
0
6
48
1.25
0.20
1.2
1.2
—
—
—
0
0
16
185
0.86
0.18
1.1
1.2
—
—
—
0
0
478
4703
1.03
0.17
12.4
19.3
1.23
1.38
inr
7.39
400
3999
9
80
1.13
0.15
1.1
1.2
—
—
—
0
0
68
717
0.95
0.15
1.4
1.7
—
—
—
0
0
11
93
1.18
0.14
1.2
1.8
—
—
—
0
0
129
1336
0.96
0.14
4.0
5.6
1.07
1.04
mmol/l
0.35
121
1227
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
37
398
0.93
0.14
2.0
2.4
0.33
0.36
iu/ml
0.21
22
217
86
897
0.96
0.13
3.0
3.0
4.20
4.41
kpa
0.51
81
868
9
107
0.84
0.13
1.1
1.0
—
—
—
0
0
77
803
0.96
0.12
2.3
2.6
38.84
36.70
u/l
0.12
67
662
11
96
1.15
0.10
1.0
1.3
102.80
260.13
pmol/l
—
5
82
57
595
0.96
0.09
7.8
9.4
15.60
15.65
%
0.05
50
576
35
330
1.06
0.09
1.1
2.0
34.25
37.66
u/l
0.52
29
281
11
97
1.14
0.09
1.2
1.8
—
—
—
0
0
6
54
1.11
0.09
1.2
1.1
—
—
—
0
0
5
61
0.82
0.08
2.8
2.5
—
—
—
0
0
5
62
0.81
0.08
1.0
1.3
—
—
—
0
0
5
64
0.78
0.08
1.0
1.4
—
—
—
0
0
5
64
0.78
0.08
1.2
1.0
—
—
—
0
0
6
75
0.80
0.07
1.0
1.5
—
268.33
—
0
6
8
91
0.88
0.06
1.3
1.6
309.63
285.37
mu/l
—
8
83
65
666
0.97
0.05
6.2
6.0
25.45
24.30
mmol/l
0.99
59
641
13
121
1.08
0.03
1.6
2.5
24.00
19.72
mg/l
—
7
43
105
1035
1.02
0.03
3.0
3.7
1.93
1.94
mmol/l
0.01
86
873
10
92
1.09
0.03
1.0
1.1
36.80
56.25
iu/ml
—
5
12
18
189
0.95
0.03
1.2
1.2
—
—
—
0
0
33
340
0.97
0.03
1.3
1.3
—
—
—
0
0
35
340
1.03
0.03
5.3
3.6
4.26
4.35
pmol/l
0.14
30
298
18
188
0.96
0.02
1.2
1.2
—
—
—
0
0
24
248
0.97
0.02
1.3
1.3
—
—
—
0
0
108
1070
1.01
0.02
3.0
3.6
5.77
5.84
kpa
0.23
103
1036
18
176
1.02
0.00
3.1
6.0
1467.83
330.68
iu/ml
—
6
25
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
0.18
—
0
8
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
6
64
0.94
0.00
1.2
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.4
—
82.86
—
0
7
5
56
0.89
-0.00
1.2
1.1
2.04
2.03
mmol/l
—
5
51
5
59
0.85
-0.00
1.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
8.24
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
97
0.93
-0.00
1.4
1.3
0.51
0.68
nmol/l
—
9
90
6
69
0.87
-0.00
1.0
1.4
—
34.29
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
18.07
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
6.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
73.40
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
6.26
—
0
5
40
400
1.00
-0.00
1.8
3.5
122.17
10722.67
u/ml
0.88
35
338
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
62
0.97
-0.00
1.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: HLP_C3_SCLC – Small cell lung cancer, helper endpoint
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).